GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Condition:   Biliary Tract Carcinoma Intervention:   Combination Product: Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab Sponsor:   Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials